Algorithms in combination with risk factors have been developed for clinical risk assessment of recurrence and have for Danish breast cancer patients been extended to allow calculation of a prognostic standard mortality rate (SMR) index (PSI) algorithm based on a comprehensive study of >6500 postmenopausal patients with ER positive high‐risk breast cancer 12, 13. The gene discussed is ESR1; the disease is breast cancer.